Cardiac implantable electronic device infection in patients with end-stage renal disease

Avirup Guha, William R. Maddox, Rhonda Elizabeth Colombo, Norris Stanley Nahman, Kristina W. Kintziger, Jennifer L Waller, Matthew J Diamond, Michele Murphy, Mufaddal Kheda, Sheldon E. Litwin, Robert A Sorrentino

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Introduction Cardiac implantable electronic devices (CIED) are increasingly being used in end-stage renal disease (ESRD) patients. These patients have a high risk of device infection. Objectives To study the optimal management of device infections in patients with ESRD. Method We used the United States Renal Data System (USRDS) to assess the presence of a CIED and associated comorbidities, risk factors for infection, and mortality following device extraction or medical management in ESRD patients with CIED infection. Univariable, multivariable, and survival analyses were performed using USRDS data from 2005 to 2009. Results Of 546,769 patients, 6.4% had CIED and 8.0% of those developed CIED infection. The major risk factors for device infection were black race, temporary dialysis catheter, and body mass index >25. Patients with artificial valves were excluded from the analysis. Only 28.4% of infected CIED were removed. CIED removal was more common in those with congestive heart failure. The median time to death following diagnosis of a CIED infection was 15.7 months versus 9.2 months for those treated via device extraction versus medical-only therapy (hazard ratio: 0.75; 95% confidence interval: 0.68-0.82). Conclusion Patients with ESRD and infected CIEDs have a poor prognosis. Rates of device extraction are low, but this strategy appears to be associated with modest improvement in survival.

Original languageEnglish (US)
Pages (from-to)2395-2401
Number of pages7
JournalHeart Rhythm
Volume12
Issue number12
DOIs
StatePublished - Dec 1 2015

Fingerprint

Chronic Kidney Failure
Equipment and Supplies
Infection
Information Systems
Device Removal
Kidney
Survival Analysis
Comorbidity
Dialysis
Body Mass Index
Catheters
Heart Failure
Confidence Intervals
Survival

Keywords

  • Deviceextraction
  • Implanted cardioverter-defibrillator
  • Infection
  • Pacemaker

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Cardiac implantable electronic device infection in patients with end-stage renal disease. / Guha, Avirup; Maddox, William R.; Colombo, Rhonda Elizabeth; Nahman, Norris Stanley; Kintziger, Kristina W.; Waller, Jennifer L; Diamond, Matthew J; Murphy, Michele; Kheda, Mufaddal; Litwin, Sheldon E.; Sorrentino, Robert A.

In: Heart Rhythm, Vol. 12, No. 12, 01.12.2015, p. 2395-2401.

Research output: Contribution to journalArticle

Guha, A, Maddox, WR, Colombo, RE, Nahman, NS, Kintziger, KW, Waller, JL, Diamond, MJ, Murphy, M, Kheda, M, Litwin, SE & Sorrentino, RA 2015, 'Cardiac implantable electronic device infection in patients with end-stage renal disease', Heart Rhythm, vol. 12, no. 12, pp. 2395-2401. https://doi.org/10.1016/j.hrthm.2015.08.003
Guha, Avirup ; Maddox, William R. ; Colombo, Rhonda Elizabeth ; Nahman, Norris Stanley ; Kintziger, Kristina W. ; Waller, Jennifer L ; Diamond, Matthew J ; Murphy, Michele ; Kheda, Mufaddal ; Litwin, Sheldon E. ; Sorrentino, Robert A. / Cardiac implantable electronic device infection in patients with end-stage renal disease. In: Heart Rhythm. 2015 ; Vol. 12, No. 12. pp. 2395-2401.
@article{65d87df2e6b545ceb6f0c970d446b734,
title = "Cardiac implantable electronic device infection in patients with end-stage renal disease",
abstract = "Introduction Cardiac implantable electronic devices (CIED) are increasingly being used in end-stage renal disease (ESRD) patients. These patients have a high risk of device infection. Objectives To study the optimal management of device infections in patients with ESRD. Method We used the United States Renal Data System (USRDS) to assess the presence of a CIED and associated comorbidities, risk factors for infection, and mortality following device extraction or medical management in ESRD patients with CIED infection. Univariable, multivariable, and survival analyses were performed using USRDS data from 2005 to 2009. Results Of 546,769 patients, 6.4{\%} had CIED and 8.0{\%} of those developed CIED infection. The major risk factors for device infection were black race, temporary dialysis catheter, and body mass index >25. Patients with artificial valves were excluded from the analysis. Only 28.4{\%} of infected CIED were removed. CIED removal was more common in those with congestive heart failure. The median time to death following diagnosis of a CIED infection was 15.7 months versus 9.2 months for those treated via device extraction versus medical-only therapy (hazard ratio: 0.75; 95{\%} confidence interval: 0.68-0.82). Conclusion Patients with ESRD and infected CIEDs have a poor prognosis. Rates of device extraction are low, but this strategy appears to be associated with modest improvement in survival.",
keywords = "Deviceextraction, Implanted cardioverter-defibrillator, Infection, Pacemaker",
author = "Avirup Guha and Maddox, {William R.} and Colombo, {Rhonda Elizabeth} and Nahman, {Norris Stanley} and Kintziger, {Kristina W.} and Waller, {Jennifer L} and Diamond, {Matthew J} and Michele Murphy and Mufaddal Kheda and Litwin, {Sheldon E.} and Sorrentino, {Robert A}",
year = "2015",
month = "12",
day = "1",
doi = "10.1016/j.hrthm.2015.08.003",
language = "English (US)",
volume = "12",
pages = "2395--2401",
journal = "Heart Rhythm",
issn = "1547-5271",
publisher = "Elsevier",
number = "12",

}

TY - JOUR

T1 - Cardiac implantable electronic device infection in patients with end-stage renal disease

AU - Guha, Avirup

AU - Maddox, William R.

AU - Colombo, Rhonda Elizabeth

AU - Nahman, Norris Stanley

AU - Kintziger, Kristina W.

AU - Waller, Jennifer L

AU - Diamond, Matthew J

AU - Murphy, Michele

AU - Kheda, Mufaddal

AU - Litwin, Sheldon E.

AU - Sorrentino, Robert A

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Introduction Cardiac implantable electronic devices (CIED) are increasingly being used in end-stage renal disease (ESRD) patients. These patients have a high risk of device infection. Objectives To study the optimal management of device infections in patients with ESRD. Method We used the United States Renal Data System (USRDS) to assess the presence of a CIED and associated comorbidities, risk factors for infection, and mortality following device extraction or medical management in ESRD patients with CIED infection. Univariable, multivariable, and survival analyses were performed using USRDS data from 2005 to 2009. Results Of 546,769 patients, 6.4% had CIED and 8.0% of those developed CIED infection. The major risk factors for device infection were black race, temporary dialysis catheter, and body mass index >25. Patients with artificial valves were excluded from the analysis. Only 28.4% of infected CIED were removed. CIED removal was more common in those with congestive heart failure. The median time to death following diagnosis of a CIED infection was 15.7 months versus 9.2 months for those treated via device extraction versus medical-only therapy (hazard ratio: 0.75; 95% confidence interval: 0.68-0.82). Conclusion Patients with ESRD and infected CIEDs have a poor prognosis. Rates of device extraction are low, but this strategy appears to be associated with modest improvement in survival.

AB - Introduction Cardiac implantable electronic devices (CIED) are increasingly being used in end-stage renal disease (ESRD) patients. These patients have a high risk of device infection. Objectives To study the optimal management of device infections in patients with ESRD. Method We used the United States Renal Data System (USRDS) to assess the presence of a CIED and associated comorbidities, risk factors for infection, and mortality following device extraction or medical management in ESRD patients with CIED infection. Univariable, multivariable, and survival analyses were performed using USRDS data from 2005 to 2009. Results Of 546,769 patients, 6.4% had CIED and 8.0% of those developed CIED infection. The major risk factors for device infection were black race, temporary dialysis catheter, and body mass index >25. Patients with artificial valves were excluded from the analysis. Only 28.4% of infected CIED were removed. CIED removal was more common in those with congestive heart failure. The median time to death following diagnosis of a CIED infection was 15.7 months versus 9.2 months for those treated via device extraction versus medical-only therapy (hazard ratio: 0.75; 95% confidence interval: 0.68-0.82). Conclusion Patients with ESRD and infected CIEDs have a poor prognosis. Rates of device extraction are low, but this strategy appears to be associated with modest improvement in survival.

KW - Deviceextraction

KW - Implanted cardioverter-defibrillator

KW - Infection

KW - Pacemaker

UR - http://www.scopus.com/inward/record.url?scp=84959882535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959882535&partnerID=8YFLogxK

U2 - 10.1016/j.hrthm.2015.08.003

DO - 10.1016/j.hrthm.2015.08.003

M3 - Article

C2 - 26253036

AN - SCOPUS:84959882535

VL - 12

SP - 2395

EP - 2401

JO - Heart Rhythm

JF - Heart Rhythm

SN - 1547-5271

IS - 12

ER -